Top Markets
Coin of the day
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
Rank in Stocks #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$3.21K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Rebus Holdings, Inc. (RBSH)

Category

P/B ratio for Rebus Holdings, Inc. (RBSH)
P/B ratio as of 2026 TTM: 0
According to Rebus Holdings, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Rebus Holdings, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
3.634 -
BE
- -
KR